跳至主要内容
临床试验/IRCT20190916044787N1
IRCT20190916044787N1招募中3 期

The effect of metformin on decreasing activity and severity of rheumatoid arthritis disease (pilot study)

Ahvaz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with moderate to high severity of rheumatoid arthritis based on the DAS28 scale

排除标准

  • Duration of illness over 3 years
  • There is significant kidney disorder that forbids from using metformin (GFR <30)
  • Significant heart failure (EF <50%)
  • Chronic hepatic impairment or acute liver failure
  • Having diabetes or previous and recent use of metformin
  • The last 3 months of anti-inflammatory drugs
  • New drug added to control patient symptoms during treatment

研究者

相似试验